In this review, the role of the macrophage in the pathophysiology of c
oronary artery disease (CAD) is examined. The central interaction of m
acrophage, endothelial cell and smooth muscle cell in the context of h
yperlipidemia is considered. The macrophage appears to be at the begin
ning of a chain of events that starts with elevated low density lipopr
otein (LDL). Stress, particularly in those with a core hostility, may
be associated not only with higher catecholamine levels but also with
higher serum lipid levels, These lipids will in turn be processed to o
xidized LDL by macrophage and endothelial cells. Oxidized LDL molecule
s will contribute to atherosclerotic plaquing. A side effect of such p
laque formation may be a diminished vasodilatory response to the nitri
c oxide (NO) produced by macrophages and endothelium. Indeed, paradoxi
cal vasoconstriction occurs in atherosclerosis in response to neurotra
nsmitters such as serotonin and acetylcholine, which under normal circ
umstances cause vasodilation. There also is evidence that both macroph
ages and endothelial cells can regulate NO production through a specif
ic mu 3 morphine receptor, an effect that can be blocked by naloxone.
The clinical effectiveness of morphine and nitroglycerin in CAD patien
ts may relate to these mechanisms. More research will be needed to elu
cidate the neuroimmunologic basis for atherosclerosis with prospects f
or better treatment and management in future. Copyright (C) 1996 Elsev
ier Science Ltd